Ionis Pharmaceuticals, Inc. (IONS) Discusses Detailed Phase III Results for Olezarsen in Severe Hypertriglyceridemia Transcript
PresentationOperator Good afternoon, and welcome to Ionis' conference call to discuss olezarsen, Phase III detailed results. As a reminder, this call is being recorded. At this time, I would like to turn the conference over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin. ...